Heart Surgery

Latest Issue of OR Manager
October 2024
Home Surgery/Specialties > Heart Surgery

Researchers test alternative approach to ranking US heart transplant candidates

Editor's Note The current method for identifying heart transplant candidates with the most urgent need might not be the best one. In a study published February 13 in Jama Network, a candidate risk score incorporating the latest clinical, laboratory, and hemodynamic data out-performed the current treatment-based categorical allocation system.  …

Read More

By: Matt Danford
February 29, 2024
Share

CNOR specialty designations distinguish uncommon skillsets

The Competency & Credentialing Institute (CCI) is excited to announce a new development in our certified perioperative nurse (CNOR®) certification program: the introduction of specialty designations. Now, perioperative nurses can specialize in cardiac, bariatric, orthopedic, or vascular surgery, just as RNs can choose oncology, pediatrics, or emergency. A specialty designation…

Read More

By: Melissa R. Nosik, PhD, BCBA-D, ICE-CCP, SHRM-SCP and Dawn Whiteside, DNP, MSN-Ed, RN, CNOR, NPD-BC, RNFA
February 27, 2024
Share

Study: Intravascular imaging for stent guidance improves outcomes for heart disease patients

Editor's Note Using intravascular imaging to guide stent implantation during percutaneous coronary intervention (PCI) provides significantly better outcomes than angiography, according to findings published February 21 in The Lancet. In a study of 15,964 patients undergoing PCI from 22 trials in hundreds of centers from March 2010 to August 2023,…

Read More

By: Brita Belli
February 22, 2024
Share

Transcatheter therapy system becomes first to earn FDA approval for treating tricuspid regurgitation

Editor's Note Patients with severe cases of tricuspid regurgitation (in which a critical heart valve fails to close properly) now have a new treatment option thanks to the recent US Food and Drug Administration (FDA) approval of the ENVOQUE tricuspid valve replacement system, according to a February 2 press release…

Read More

By: Matt Danford
February 14, 2024
Share

Sponsored Message

Biorobotic heart shows promise for research, surgical training

Editor's Note:  Surgeons successfully tested three fixes for a leaky heart valve on a biological pig heart fitted with a silicone robotic pump, HealthDay reported on January 11. According to the article, the biorobotic heart offers significant advantages over existing heart simulators. These include a longer shelf life, greater ability…

Read More

By: Matt Danford
January 22, 2024
Share

Scientists uncover new path to regenerate injured hearts

Editor's Note Researchers are studying how heart muscle cells called cardiomyocytes can be repaired and regenerated to improve functioning and help prevent more serious long-term consequences. The study, titled “Reduced mitochondrial protein translation promotes cardiomyocyte proliferation and heart regeneration,” was published by the journal Circulation—part of the American Heart Association—on…

Read More

By: Brita Belli
December 11, 2023
Share

Sponsored Message

New calculator determines likelihood of developing cardiovascular disease

Editor's Note For the first time, researchers have designed a calculator that estimates a person’s risk for developing cardiovascular disease (CVD) over the next 30 years. The news was announced in a statement from the American Heart Association in the journal Circulation on November 10. 1 in 3 U.S. adults…

Read More

By: Brita Belli
November 10, 2023
Share

Study: Redo TAVR procedures safe, effective

Editor's Note This study by researchers at Cedars-Sinai Medical Center, Los Angeles, finds that redo transcatheter aortic valve replacement (TAVR) procedures are both safe and effective. Of 350,591 patients in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry who underwent TAVR with balloon-expandable valves between November…

Read More

By: Judy Mathias
September 5, 2023
Share

FDA: Class I recall of Cardiosave Hybrid, Rescue IABPs

Editor's Note The Food and Drug Administration (FDA), on August 31, identified the recall by Getinge/Maquet/Datasocpe of its Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) as Class I, the most serious. The FDA posted four recalls for four separate reasons: Because they may overheat when the device’s internal temperature…

Read More

By: Judy Mathias
September 5, 2023
Share

LivaNova receives FDA 510(k) approval for new in-line blood monitor

Editor's Note The Essenz™ In-Line Blood Monitor (ILBM) has received U.S. FDA 510(k) clearance and CE mark, as announced by manufacturer LivaNova on August 30. The new ILBM provides “accurate and continuous measurement of essential blood parameters for perfusionists throughout cardiopulmonary bypass procedures,” and integrates with the company’s Essenz Perfusion…

Read More

By: Lindsay Botts
September 1, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat